Abstract
Various congenital, traumatic, toxic, and autoimmune processes may lead to limbal stem cell dysfunction (LSCD). In the past, patients with LSCD suffered from permanent loss of visual function as the condition was difficult to manage. In recent decades, research in this area has led to novel treatment paradigms. It was discovered that significant corneal injury in patients with LSCD can lead to not only a decreased number of corneal epithelial progenitor cells but also a disturbance in the limbal stem cell niche. Under these pathological conditions, a pro-inflammatory environment persists in patients with LSCD, leading to continued activation of inflammatory cytokines, impaired macrophage phagocytosis, and pathological hemangiogenesis. Thus, the current strategy in corneal regeneration in this area is a two-pronged approach, including both direct repopulation of limbal epithelial stem cells (LESCs) and also restoration of the limbal stem cell niche. In this chapter, a summary of current approaches to corneal epithelial regeneration will be provided. Novel research into possible future approaches to corneal regeneration including the use of mesenchymal stem cells will also be discussed (Fig. 20.1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Dua HS, Shanmuganathan VA, Powell-Richards AO, Tighe PJ, Joseph A. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol. 2005;89:529–32.
Grieve K, et al. Three-dimensional structure of the mammalian limbal stem cell niche. Exp Eye Res. 2015;140:75–84.
Dziasko MA, et al. Localisation of epithelial cells capable of holoclone formation in vitro and direct interaction with stromal cells in the native human limbal crypt. PLoS One. 2014;9:e94283.
Mathews S, et al. In vivo confocal microscopic analysis of normal human anterior limbal stroma. Cornea. 2015;34:464–70.
Higa K, et al. Aquaporin 1-positive stromal niche-like cells directly interact with N-cadherin-positive clusters in the basal limbal epithelium. Stem Cell Res. 2013;10:147–55.
Yamada K, et al. Mesenchymal-epithelial cell interactions and proteoglycan matrix composition in the presumptive stem cell niche of the rabbit corneal limbus. Mol Vis. 2015;21:1328–39.
Xie H-T, Chen S-Y, Li G-G, Tseng SCG. Limbal epithelial stem/progenitor cells attract stromal niche cells by SDF-1/CXCR4 signaling to prevent differentiation. Stem Cells. 2011;29:1874–85.
Han B, Chen S-Y, Zhu Y-T, Tseng SCG. Integration of BMP/Wnt signaling to control clonal growth of limbal epithelial progenitor cells by niche cells. Stem Cell Res. 2014;12:562–73.
Cornea, 2-Volume Set, 4th ed. Mannis & Holland. (Elsevier, 2017).
Sharma SM, et al. Comparative analysis of human-derived feeder layers with 3T3 fibroblasts for the ex vivo expansion of human limbal and oral epithelium. Stem Cell Rev. 2012;8:696–705.
Miyashita H, et al. A novel NIH/3T3 duplex feeder system to engineer corneal epithelial sheets with enhanced cytokeratin 15-positive progenitor populations. Tissue Eng Part A. 2008;14:1275–82.
Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6:331–43.
Ramírez BE, et al. Stem cell therapy for corneal epithelium regeneration following good manufacturing and clinical procedures. Biomed Res Int. 2015;2015:408495.
Levis HJ, Brown RA, Daniels JT. Plastic compressed collagen as a biomimetic substrate for human limbal epithelial cell culture. Biomaterials. 2010;31:7726–37.
Tidu A, et al. Development of human corneal epithelium on organized fibrillated transparent collagen matrices synthesized at high concentration. Acta Biomater. 2015;22:50–8.
Duan X, Sheardown H. Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions. Biomaterials. 2006;27:4608–17.
Brown KD, et al. Plasma polymer-coated contact lenses for the culture and transfer of corneal epithelial cells in the treatment of limbal stem cell deficiency. Tissue Eng Part A. 2014;20:646–55.
Rama P, et al. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation. 2001;72:1478–85.
Sotozono C, et al. Visual improvement after cultivated oral mucosal epithelial transplantation. Ophthalmology. 2013;120:193–200.
Nakamura T, et al. Phenotypic investigation of human eyes with transplanted autologous cultivated oral mucosal epithelial sheets for severe ocular surface diseases. Ophthalmology. 2007;114:1080–8.
Ricardo JRS, et al. Transplantation of conjunctival epithelial cells cultivated ex vivo in patients with total limbal stem cell deficiency. Cornea. 2013;32:221–8.
Jeon S, Choi SH, Wolosin JM, Chung S-H, Joo C-K. Regeneration of the corneal epithelium with conjunctival epithelial equivalents generated in serum- and feeder-cell-free media. Mol Vis. 2013;19:2542–50.
Hayashi R, et al. Co-ordinated ocular development from human iPS cells and recovery of corneal function. Nature. 2016;531:376–80.
Hayashi R, et al. Coordinated generation of multiple ocular-like cell lineages and fabrication of functional corneal epithelial cell sheets from human iPS cells. Nat Protoc. 2017;12:683–96.
Zakaria N, et al. Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation. J Transl Med. 2014;12:58.
Behaegel J, Ní Dhubhghaill S, Koppen C, Zakaria N. Safety of cultivated limbal epithelial stem cell transplantation for human corneal regeneration. Stem Cells Int. 2017;2017:6978253.
Haagdorens M, et al. Limbal stem cell deficiency: current treatment options and emerging therapies. Stem Cells Int. 2016;2016:9798374.
Kojima T, et al. Autologous serum eye drops for the treatment of dry eye diseases. Cornea. 2008;27(Suppl 1):S25–30.
Soni NG, Jeng BH. Blood-derived topical therapy for ocular surface diseases. Br J Ophthalmol. 2016;100:22–7.
López-Plandolit S, Morales M-C, Freire V, Grau AE, Durán JA. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea. 2011;30:1312–7.
Freire V, et al. Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study. Cornea. 2014;33:614–20.
John T. Human amniotic membrane transplantation: past, present, and future. Ophthalmol Clin N Am. 2003;16:43–65, vi.
Rahman I, Said DG, Maharajan VS, Dua HS. Amniotic membrane in ophthalmology: indications and limitations. Eye (Lond). 2009;23:1954–61.
Optimizing the ocular surface with amniotic membrane therapy | Ophthalmology Magazine. Available at: https://www.eyeworld.org/optimizing-ocular-surface-amniotic-membrane-therapy. Accessed: 1 Jan 2018.
Paolin A, et al. Amniotic membranes in ophthalmology: long term data on transplantation outcomes. Cell Tissue Bank. 2016;17:51–8.
Campbell JDM, et al. Allogeneic ex vivo expanded corneal epithelial stem cell transplantation: a randomized controlled clinical trial. Stem Cells Transl Med. 2019; https://doi.org/10.1002/sctm.18-0140.
Jirsova K, Jones GLA. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting-a review. Cell Tissue Bank. 2017;18:193–204.
Lu Y, et al. Characterization of a hydrogel derived from decellularized corneal extracellular matrix. 2015. https://doi.org/10.1166/jbt.2015.1410.
Shafiq MA, Gemeinhart RA, Yue BYJT, Djalilian AR. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng Part C Methods. 2012;18:340–8.
Dehghani S, et al. 3D-Printed membrane as an alternative to amniotic membrane for ocular surface/conjunctival defect reconstruction: an in vitro & in vivo study. Biomaterials. 2018;174:95–112.
Abdel-Naby W, et al. Silk-derived protein enhances corneal epithelial migration, adhesion, and proliferation. Invest Ophthalmol Vis Sci. 2017;58:1425–33.
Lawrence BD, Pan Z, Rosenblatt MI. Silk film topography directs collective epithelial cell migration. PLoS One. 2012;7:e50190.
Kang KB, et al. Micro- and nanoscale topographies on silk regulate gene expression of human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2017;58:6388–98.
Mittal SK, et al. Restoration of corneal transparency by mesenchymal stem cells. Stem Cell Reports. 2016;7:583–90.
Davies BW, Panday V, Caldwell M, Scribbick F, Reilly CD. Effect of topical immunomodulatory interleukin 1 receptor antagonist therapy on corneal healing in New Zealand white rabbits (Oryctolagus cunniculus) after photorefractive keratectomy. Arch Ophthalmol. 2011;129:909–13.
Lan Y, et al. Kinetics and function of mesenchymal stem cells in corneal injury. Invest Ophthalmol Vis Sci. 2012;53:3638–44.
Acar U, et al. Effect of allogeneic limbal mesenchymal stem cell therapy in corneal healing: role of administration route. Ophthalmic Res. 2015;53:82–9.
Eslani M, et al. Cornea-derived mesenchymal stromal cells therapeutically modulate macrophage immunophenotype and angiogenic function. Stem Cells. 2018;36:775–84.
Samaeekia R, et al. Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2018;59:5194–200.
Eslani M, et al. Corneal mesenchymal stromal cells are directly antiangiogenic via PEDF and sFLT-1. Invest Ophthalmol Vis Sci. 2017;58:5507–17.
Yazdanpanah G, et al. Strategies for reconstructing the limbal stem cell niche. Ocul Surf. 2019; https://doi.org/10.1016/j.jtos.2019.01.002.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kang, K.B., Rosenblatt, M.I., D’jalilian, A.R. (2020). Novel Approaches for Restoring the Function of the Limbal Stem Cell Niche. In: Colby, K., Dana, R. (eds) Foundations of Corneal Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-25335-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-25335-6_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25334-9
Online ISBN: 978-3-030-25335-6
eBook Packages: MedicineMedicine (R0)